Search Results - "Kurth RI"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.

    Authors: Miyazaki I Odintsov I Ishida K et al.

    Source: Nature cancer [Nat Cancer] 2023 Oct; Vol. 4 (10), pp. 1526.

    Publication Type: Published Erratum

    Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE; PubMed not MEDLINE

    Save to List
  2. 2

    Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.

    Authors: Miyazaki I Odintsov I Ishida K et al.

    Source: Nature cancer [Nat Cancer] 2023 Sep; Vol. 4 (9), pp. 1345-1361. Date of Electronic Publication: 2023 Sep 21.

    Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

    Save to List
  3. 3

    The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions.

    Authors: Odintsov I Lui AJW Sisso WJ et al.

    Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jun 01; Vol. 27 (11), pp. 3154-3166. Date of Electronic Publication: 2021 Apr 06.

    Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

    Save to List

Search Tools: